Company Profile

PanGenex Inc
Profile last edited on: 12/14/06      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2000
First Award
2002
Latest Award
2006
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

201 Elliott Avenue West Suite 400
Seattle, WA 98119
   (206) 282-7100
   N/A
   www.pangenex.com
Location: Single
Congr. District: 07
County: King

Public Profile

PanGenex, Inc., was acquired by Cell Therapeutics. PanGenex, Inc., is a majority-owned subsidiary of Cell Therapeutics, Inc, founded to focus on identifying novel drug development targets using the recently completed human genome sequence database. PanGenex, Inc. will have the technological advantage to rapidly sift through the exceptionally large quantity of human genome data to identify the minority of human genes that are valid targets for drug discovery. Because the technologies can potentially be automated and employed on a large scale, they could eliminate a major bottleneck in the identification of new drug candidates that are effective against human diseases.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2006 2 NIH $1,393,291
Project Title: Target Validation using Gene Knockouts in Somatic Cells

Key People / Management

  Robert E Finney -- President

Company News

There are no news available.